Search results for " 2018"
Article
Biosimilars Will Bring Significant Litigation and Patent Challenges
Provided FDA begins approving antibody-based biosimilars, she expects to see an increase in litigation for these medications in 2018 or 2019.
Sources:
Nature
GEN
Article
Q&As with Industry Leaders
Mats Lundgren, Customer Applications Director at Cytiva
State of the Biopharmaceutical Industry: Lessons from 2018 Survey Data
…
Article
Biotechnology Innovation and Growth in Israel
In 2011, Merck KGaA’s subsidiary Merck Serono invested US$13 million in a new drug development incubator with the goal of having at least six startups working on new medications or technologies by 201…